ES526446A0 - Procedimiento para la preparacion de nuevos 6 -metilcorticoides - Google Patents

Procedimiento para la preparacion de nuevos 6 -metilcorticoides

Info

Publication number
ES526446A0
ES526446A0 ES526446A ES526446A ES526446A0 ES 526446 A0 ES526446 A0 ES 526446A0 ES 526446 A ES526446 A ES 526446A ES 526446 A ES526446 A ES 526446A ES 526446 A0 ES526446 A0 ES 526446A0
Authority
ES
Spain
Prior art keywords
methyl
korticoids
procedure
preparation
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES526446A
Other languages
English (en)
Other versions
ES8405421A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of ES8405421A1 publication Critical patent/ES8405421A1/es
Publication of ES526446A0 publication Critical patent/ES526446A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Seasonings (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
ES526446A 1982-11-22 1983-10-13 Procedimiento para la preparacion de nuevos 6 -metilcorticoides Granted ES526446A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823243482 DE3243482A1 (de) 1982-11-22 1982-11-22 Neue 6(alpha)-methylkortikoide, ihre herstellung und verwendung

Publications (2)

Publication Number Publication Date
ES8405421A1 ES8405421A1 (es) 1984-06-16
ES526446A0 true ES526446A0 (es) 1984-06-16

Family

ID=6178924

Family Applications (1)

Application Number Title Priority Date Filing Date
ES526446A Granted ES526446A0 (es) 1982-11-22 1983-10-13 Procedimiento para la preparacion de nuevos 6 -metilcorticoides

Country Status (22)

Country Link
US (1) US4645763A (es)
EP (1) EP0110041B1 (es)
JP (1) JPS59106500A (es)
AT (1) ATE28651T1 (es)
AU (1) AU2098983A (es)
BG (2) BG43867A3 (es)
CA (1) CA1303607C (es)
CS (1) CS248712B2 (es)
DD (1) DD219200A5 (es)
DE (2) DE3243482A1 (es)
DK (1) DK159686C (es)
ES (1) ES526446A0 (es)
GB (1) GB2130587A (es)
GR (1) GR79725B (es)
HU (1) HU190746B (es)
IE (1) IE56281B1 (es)
IL (1) IL70160A (es)
NO (1) NO157454C (es)
PL (3) PL141686B1 (es)
PT (1) PT77408B (es)
RO (2) RO93593B (es)
ZA (1) ZA838720B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60161914A (ja) * 1984-02-02 1985-08-23 Green Cross Corp:The ステロイド脂肪酸エステル含有直腸投与製剤
JPS61274795A (ja) * 1985-05-30 1986-12-04 Toshiba Corp 曝気槽の溶存酸素濃度制御装置
US4968822A (en) * 1987-12-11 1990-11-06 Taisho Pharmaceutical Co., Ltd. 21-alkoxysteroid compounds
AU7556291A (en) * 1990-03-27 1991-10-21 Schering Corporation Process for 9alpha-hydroxy steroid dehydration
DE4333920A1 (de) * 1993-10-05 1995-04-13 Hoechst Ag Corticoid-17,21-dicarbonsäureester sowie Corticosteroid-17-carbonsäureester-21-kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
ITMI20011762A1 (it) 2001-08-10 2003-02-10 Cosmo Spa Esteri di 17alfa,21-diidrossipregnene, loro uso come agenti anti-androgenetici e procedimenti per la loro preparazione
ITMI20071616A1 (it) 2007-08-03 2009-02-04 Cosmo Spa Processo enzimatico per l'ottenimento di 17-alfa monoesteri del cortexolone e/o suoi 9,11-deidroderivati.
KR101591482B1 (ko) * 2008-05-28 2016-02-03 레베라겐 바이오파마 인코포레이티드 질환의 치료를 위한 ＮＦ-κＢ 의 비호르몬성 스테로이드 조절제
EP2556083A4 (en) 2010-04-05 2013-12-04 Validus Biopharma Inc NONHORMONAL STEROID MODULATORS OF NF-KAPPA-B FOR DISEASE TREATMENT
EP3108879A1 (en) 2015-06-25 2016-12-28 Cassiopea S.p.A. High concentration formulation
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3053832A (en) * 1957-04-29 1962-09-11 Schering Corp Alkylated cortical steroids
GB921533A (en) * 1958-07-12 1963-03-20 Syntex Sa Cyclopentanophenanthrene derivatives and process for the production thereof
GB1047518A (en) * 1963-06-11 1966-11-02 Glaxo Lab Ltd 17ª‡-monoesters of 11,17,21-trihydroxy steroid compounds
DE2645104C2 (de) * 1976-10-04 1986-04-24 Schering AG, 1000 Berlin und 4709 Bergkamen 11β-Hydroxy-1,4,8-pregnatrien-3,20-dion-Derivate und Verfahren zu ihrer Herstellung
US4243586A (en) * 1980-01-18 1981-01-06 E. R. Squibb & Sons, Inc. Steroidal-17-spiro-dihydrofuranones
US4318853A (en) * 1980-01-31 1982-03-09 The Upjohn Company 9β,11β-Epoxy-5β-corticoids
US4336200A (en) * 1980-01-31 1982-06-22 The Upjohn Company 17α-Acyloxy-5β-corticoids
DE3169460D1 (en) * 1980-12-23 1985-04-25 Schering Ag 6-alpha-methyl hydrocortisone derivatives, their preparation and their utilization

Also Published As

Publication number Publication date
PL244685A1 (en) 1985-04-24
GR79725B (es) 1984-10-31
DE3243482A1 (de) 1984-05-24
EP0110041B1 (de) 1987-07-29
PT77408B (de) 1986-02-27
JPH0415799B2 (es) 1992-03-19
RO93593A (ro) 1987-12-31
CS248712B2 (en) 1987-02-12
PT77408A (de) 1983-10-01
HU190746B (en) 1986-10-28
IE56281B1 (en) 1991-06-05
DK159686C (da) 1991-04-15
BG42677A3 (en) 1988-01-15
PL250735A1 (en) 1985-07-30
ES8405421A1 (es) 1984-06-16
EP0110041A1 (de) 1984-06-13
PL141686B1 (en) 1987-08-31
ATE28651T1 (de) 1987-08-15
CA1303607C (en) 1992-06-16
GB2130587A (en) 1984-06-06
DK533783A (da) 1984-05-23
NO157454B (no) 1987-12-14
RO89343A (ro) 1986-03-15
NO834265L (no) 1984-05-23
DD219200A5 (de) 1985-02-27
PL138796B1 (en) 1986-11-29
DE3372776D1 (en) 1987-09-03
RO93593B (ro) 1988-01-01
IL70160A0 (en) 1984-02-29
GB8327736D0 (en) 1983-11-16
NO157454C (no) 1988-03-23
PL250734A1 (en) 1985-07-30
BG43867A3 (en) 1988-08-15
US4645763A (en) 1987-02-24
ZA838720B (en) 1984-07-25
AU2098983A (en) 1984-05-31
IL70160A (en) 1988-03-31
DK533783D0 (da) 1983-11-22
DK159686B (da) 1990-11-19
JPS59106500A (ja) 1984-06-20
IE832708L (en) 1984-05-22

Similar Documents

Publication Publication Date Title
ES526446A0 (es) Procedimiento para la preparacion de nuevos 6 -metilcorticoides
ES515081A0 (es) "procedimiento para la preparacion de derivados de 6-metilprednisolona".
AU548396B2 (en) 2-aryl-3,4-diazabicyclo(4.n.0)alk-2-en-5-ones
ES546040A0 (es) Un procedimiento para producir 1a,25-dihidroxi-26,27-dime- tilcolecalciferol
ES524238A0 (es) "procedimiento para la preparacion de 6,16-dimetilcorticoides"
AU623805B2 (en) New use of anti-progestomimetic compounds
IE833006L (en) Substituted azabicycloalkanes.
AU584098B2 (en) Substituted azabicycloheptanes, the use thereof, pharmaceutical preparations that contain these compounds, and processes for the manufacture of these compounds
ES526898A0 (es) Procedimiento para la preparacion de nuevas 7 -aciltio-1 ,2 -metilen-3-oxo-17 -pregn-4-en-21,17-carbolactonas
FI864329A0 (fi) 1-metyl-15 -alkylandrosta-1,4-dien -3,17-dioner foerfaranden foer deras framstaellning och laekemedelspreparat innehaollande dessa. x
ES505328A0 (es) Procedimiento para la preparacion de cardenolido-bis-digoto-xosidos

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20041102